Ocular Therapeutix, Inc
OCUL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001393434
In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Ocular Therapeutix, Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 123 | 130 | +7 |
| Shares | 44.3M | 42.8M | −1.53M (−3.5%) |
| Value | $178.2M | $177.6M | −$594.3K (−0.3%) |
New holders (21)
Institutions that held Ocular Therapeutix, Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 531,636 | $2.21M | 0.01% |
| Ikarian Capital, LLC | 265,000 | $1.10M | 0.55% |
| Two Sigma Investments, LP | 197,760 | $821.0K | 0.00% |
| Graham Capital Management, L.P. | 190,121 | $789.0K | 0.03% |
| Ergoteles LLC | 119,265 | $495.0K | 0.02% |
| Jacobs Levy Equity Management, Inc | 100,809 | $418.0K | 0.00% |
| Boothbay Fund Management, LLC | 47,381 | $197.0K | 0.01% |
| Russell Investments Group, Ltd. | 30,943 | $128.0K | 0.00% |
| Fox Run Management, L.L.C. | 25,597 | $106.0K | 0.04% |
| STRS Ohio | 15,900 | $65.0K | 0.00% |
| Creative Planning | 15,394 | $64.0K | 0.00% |
| ExodusPoint Capital Management, LP | 13,402 | $56.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 13,274 | $55.0K | 0.01% |
| HRT Financial LP | 10,868 | $45.0K | 0.00% |
| State of Wyoming | 9,740 | $40.0K | 0.02% |
| US Bancorp | 3,011 | $12.0K | 0.00% |
| Signaturefd, LLC | 1,195 | $5.00K | 0.00% |
| Lindbrook Capital, LLC | 677 | $3.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 721 | $3.00K | 0.00% |
| Credit Suisse AG | 440 | $2.00K | 0.00% |
| Massmutual Trust Co FSB | 61 | $0 | 0.00% |
Sold out (14)
Institutions that held Ocular Therapeutix, Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| MSD Partners, L.P. | 1,016,302 | $4.09M |
| Bank of Montreal | 511,195 | $2.16M |
| Kamunting Street Capital Management, L.P. | 275,506 | $1.11M |
| Gsa Capital Partners LLP | 127,978 | $514.0K |
| Fred Alger Management, LLC | 45,987 | $185.0K |
| Versor Investments LP | 33,400 | $134.0K |
| Ensign Peak Advisors, Inc | 29,050 | $117.0K |
| Balyasny Asset Management LLC | 18,459 | $74.0K |
| Bayesian Capital Management, LP | 16,200 | $65.0K |
| Acuta Capital Partners, LLC | 13,171 | $53.0K |
| Victory Capital Management Inc | 10,137 | $41.0K |
| Ahrens Investment Partners LLC | 8,000 | $32.0K |
| Point72 Hong Kong Ltd | 4,162 | $17.0K |
| National Bank of Canada | 2,370 | $10.0K |